What are peptides? A plain, evidence-first explainer

What is a peptide, actually?

Most people arrive here the same way. You saw the word on a product label, or someone in a forum named one.

Then you went looking, and every explanation was either a chemistry lecture or a sales page.

So here's the plain version.

A peptide is a short chain of amino acids, which are the same small molecules your body uses to build proteins.²

Think of amino acids as loose building blocks scattered on the floor. Snap a few together and you've got a small tower, and that tower is a peptide. Keep going until it's big enough to fold into a castle with rooms and doors, and you've got a protein.

Your body already makes thousands of these short chains. Many of them work as signaling molecules, carrying an instruction from one cell to another: release insulin, or stop feeling hungry.

That's what makes them interesting as medicine. If a molecule already carries instructions your body listens to, you can try designing one that carries an instruction you want.

The word itself tells you nothing about whether a peptide is safe or whether it works. "Peptide" describes a molecule's shape, roughly the way "pill" describes a medicine's shape.

Two peptides can look nearly identical on paper and sit at opposite ends of the evidence spectrum. One might be an approved drug tested in tens of thousands of people. The one beside it on the same vendor page might have nothing behind it but a few mouse studies.

How is a peptide different from a protein?

Length is the main answer, and it has real consequences.

Peptides are short, usually somewhere between 2 and 50 amino acids, and they mostly stay loose and floppy. Proteins run to hundreds or thousands of links and fold into precise shapes, and that shape is what lets them do a specific job.

They also behave differently from the small molecules in most pills. Peptides are much bigger, and they tend to hit their target more selectively.

They also have to be injected, almost always. Your digestive system takes them apart before they can reach the bloodstream.

That last point is worth carrying with you while shopping. When a product promises peptide benefits in a capsule, the seller owes you an explanation of how it survives digestion. Usually there isn't one.

Which peptides are FDA-approved, and which aren't?

Only a minority, and the approved ones are a much narrower group than the marketing around peptides suggests.

Semaglutide and tirzepatide are approved for diabetes and weight management. Liraglutide and tesamorelin are approved for their own defined uses. Most of the compounds that dominate peptide forums are nowhere on the list.

Here's the part that catches people out: an approval covers one exact molecule, in one formulation, for one medical use.¹

A similar-looking compound sold "for research purposes only" does not inherit that approval. The chemistry can be close and the name nearly identical, and it still doesn't carry over.

Compounded versions sit in their own regulatory category, with their own rules.³

To check where any specific compound sits, our peptide research directory tracks status compound by compound.

What does "99% pure" actually tell you?

Less than you'd think, and this is where our own data says something no vendor page will.

We keep an open testing ledger of 117 certificates of analysis, covering 11 compounds and 38 named parties. Every record links back to the original lab document.⁵

Two of them make the point better than any explanation could.

Both are GHK-Cu. Both are labelled 100mg. Both came back over 99% pure.

One vial held nearly a quarter less than its label promised. The other held nearly a quarter more.

Both would pass a purity check with room to spare.

Purity and quantity are separate questions, and answering one doesn't answer the other.

Purity estimates how much of the material in the vial is the compound on the label. Quantity asks whether the vial holds as much as it claims. Neither says anything about sterility.

To work through one of these documents line by line, see our guide to reading a certificate of analysis.

Why do prices vary so wildly?

We re-read vendor catalogs every week and keep every price with the date we saw it. As of the July 2026 check, that's 706 individual offers across 60 peptides and 28 vendors.

The spreads are large enough to be worth naming:

A 5x spread on the same compound looks alarming at first. Then you notice these are package prices, not per-milligram prices.

Different vial sizes, quantities, and shipping origins are all buried inside those numbers. That's why comparing headline prices is close to meaningless.

What the range does tell you is that this market has no price discipline. You can't read quality off a price tag in either direction.

Our price market breaks each compound down by vendor and observation date, so you can compare like with like. We've also written about why weight-care pricing is so hard to compare honestly.

How should I judge the evidence for a specific peptide?

Start by working out where a compound sits on the road from idea to medicine, because almost every argument about peptides is really a disagreement about that.

The road has a shape. Something works in a dish, then in animals, then it raises the right numbers in a few volunteers, then a real trial asks whether people actually got better, then a regulator weighs the benefits against the harms.

Most compounds you'll read about are stuck early on that road and being described as though they'd finished it.

The single most useful habit is asking what the strongest study actually measured.⁴ A trial that moved a blood marker has not shown that anyone got better, and that one distinction resolves more peptide arguments than anything else you can learn.

Two traps sit either side of it. A mechanism paper explains why something might work, which earns more research rather than your trust. And a compound being sold everywhere tells you it's easy to sell, not that it works.

Our research directory records where each compound sits, with the reasoning. The full four-question test, with worked examples, is in why evidence maturity beats online momentum.

Claims worth distrusting

These are the lines that travel fastest, and what each one actually amounts to.

"Third-party tested." Ask which sample, which batch, and which lab, then ask to see the record on the lab's own site. A screenshot is not a test result, and one test standing in for an entire catalog is not batch-level evidence.

"99.9% pure, so it's high quality." See the two GHK-Cu samples above. Purity is one column on a report that has several.

"Same as the pharmacy version." Same active molecule is not the same product. Formulation, sterility, and manufacturing controls are where the difference lives.

"Clinically proven." Proven in whom, measuring what, and compared against what? If the answer is a 12-person open-label study, the phrase is doing a lot of work it hasn't earned.

We've turned this into a working checklist in how to evaluate a peptide vendor.

Where this leaves you

If you take one thing from this page, make it the first point: "peptide" is a category, not a recommendation.

The useful question is never "are peptides good." It's two narrower questions, asked one at a time.

What does the evidence say about this compound, for this use? And what is actually in the vial you'd be buying?

We publish the raw material for both. Regulatory and evidence status sits in the research directory, lab records in the testing ledger, and vendor pricing in the price market.